Cabaletta Bio, Inc. — Director's Dealing 2023

Jun 2, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cabaletta Bio, Inc. (CABA)
CIK: 0001759138
Period of Report: 2023-06-01

Reporting Person: Bollard Catherine (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-06-01	Stock Option (Right to Buy)	$11.18	A	22000	Acquired	2033-05-31	Common Stock (22000)	Direct

Footnotes

F1: This option shall vest in full upon the earlier of (i) June 1, 2024 or (ii) the date of the next annual meeting of the Corporation's stockholders.